Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
Joshua I. Warrick, Wenhuo Hu, Hironobu Yamashita, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

FOXA1 forms biomolecular condensates that unpack condensed chromatin to function as a pioneer factor
Dengyu Ji, Changrong Shao, Juan Yu, et al.
Molecular Cell (2023) Vol. 84, Iss. 2, pp. 244-260.e7
Closed Access | Times Cited: 29
Tracing the Evolution of Sex Hormones and Receptor‐Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease
Dengxiong Li, Zhipeng Wang, Qingxin Yu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
Aleksandra Semeniuk-Wojtaś, Karolina Poddębniak-Strama, Magdalena Modzelewska, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 1971-1989
Open Access | Times Cited: 15
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4
Joshua I. Warrick, Hikmat Al‐Ahmadie, David M. Berman, et al.
The American Journal of Surgical Pathology (2023) Vol. 48, Iss. 1, pp. e32-e42
Closed Access | Times Cited: 13
Molecular subtypes of bladder cancer do not display microenvironment- or metastasis-induced plasticity
Carina Bernardo, Subhayan Chattopadhyay, Natalie Andersson, et al.
Research Square (Research Square) (2025)
Closed Access
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa Chu, Ziyu Chen, Karissa Whiting, et al.
European Urology (2025)
Closed Access
Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers
Varadha Balaji Venkadakrishnan, Yasutaka Yamada, Kenny Weng, et al.
Molecular Cancer Research (2023) Vol. 21, Iss. 6, pp. 497-510
Open Access | Times Cited: 10
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
Wolfgang Beckabir, Sara E. Wobker, Jeffrey S. Damrauer, et al.
European Urology (2023) Vol. 85, Iss. 3, pp. 242-253
Open Access | Times Cited: 10
IFNγ/JAK1/STAT1 signaling represses FOXA1 and drives a basal transcriptional state in muscle-invasive bladder cancer
Sarah H. Lawrence, Hironobu Yamashita, Lauren Shuman, et al.
American Journal Of Pathology (2025)
Open Access
PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations
Akihiro Hamada, Yuki Kita, Toru Sakatani, et al.
Oncogene (2025)
Open Access
Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma
Antara Biswas, Sarthak Sahoo, Gregory Riedlinger, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 7
Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making
Joshua I. Warrick
Advances in Anatomic Pathology (2024) Vol. 31, Iss. 3, pp. 178-187
Closed Access | Times Cited: 2
Clinical implications of single cell sequencing for bladder cancer
Reza Yadollahvandmiandoab, Mehrsa Jalalizadeh, FRANCIELE APARECIDA VECHIA DIONATO, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 4, pp. 597-605
Open Access | Times Cited: 2
Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer
Reinhard Grausenburger, Paula Herek, Shahrokh F. Shariat, et al.
Current Opinion in Urology (2024) Vol. 34, Iss. 4, pp. 236-243
Open Access | Times Cited: 2
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance
Anmbreen Jamroze, Xiaozhuo Liu, Dean G. Tang
(2024), pp. 1-35
Open Access | Times Cited: 2
Basal/squamous and Mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
Clarice S. Groeneveld, Christian Pfister, S. Culine, et al.
Annals of Oncology (2024)
Closed Access | Times Cited: 2
Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells
Aaron A. Mehus, Madison Jones, Mason Trahan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9149-9149
Open Access | Times Cited: 5
miRNome targeting NF-κB signaling orchestrates macrophage-triggered cancer metastasis and recurrence
Dong‐Ping Chen, Juncheng Wang, Zhengyu Liu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1110-1124
Closed Access | Times Cited: 1
Clinicopathologic and Molecular Characterization of High-Risk Human Papillomavirus–Positive Carcinomas of the Urinary Tract
Neslihan Kayraklioglu, Bradley A. Stohr, Emily Chan
Archives of Pathology & Laboratory Medicine (2024)
Open Access | Times Cited: 1
Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience
Yong Zhang, Qingqing Wu, Joshua I. Warrick, et al.
Annals of Diagnostic Pathology (2024) Vol. 73, pp. 152357-152357
Closed Access | Times Cited: 1
FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma
Junshang Ge, Ying Liu, Pan Chen, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010091-e010091
Open Access | Times Cited: 1
Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network
Rafaella Sousa Ferraz, João Vitor Ferreira Cavalcante, Leandro Magalhães, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 19279-19290
Open Access | Times Cited: 3
Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma
Yue Wang, Yunfan Wang, Huiying He, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Knockdown of Keratin 6 Within Arsenite-Transformed Human Urothelial Cells Decreases Basal/Squamous Expression, Inhibits Growth, and Increases Cisplatin Sensitivity
Nelofar Nargis, Donald A. Sens, Aaron A. Mehus
Cells (2024) Vol. 13, Iss. 21, pp. 1803-1803
Open Access
Molecular Classification of Urothelial Carcinoma
Jie‐Fu Chen, Hikmat Al‐Ahmadie
Surgical pathology clinics (2024) Vol. 18, Iss. 1, pp. 41-51
Closed Access
Page 1 - Next Page

Scroll to top